SCHEDULE 13G/A: Eddleman Trusts Disclose 5.93% Passive Stake in Repligen Corporation

Three trusts associated with the late Roy T. Eddleman have collectively disclosed a 5.93% passive beneficial ownership stake in Repligen Corporation's common stock as of December 31, 2024.

Summary

• The filing is an Amendment No. 7 to Schedule 13G, indicating a change in beneficial ownership or reporting status.
• The reporting persons are the Roy T. Eddleman Living Trust, Roy T. Eddleman Charitable Remainder Trust #1, and Roy T. Eddleman Charitable Remainder Trust #2.
• As of December 31, 2024, the Roy T. Eddleman Living Trust beneficially owns 2,705,689 shares, representing 4.84% of Repligen Corporation's common stock.
• The Roy T. Eddleman Charitable Remainder Trust #1 beneficially owns 441,818 shares, representing 0.79% of the common stock.
• The Roy T. Eddleman Charitable Remainder Trust #2 beneficially owns 163,992 shares, representing 0.29% of the common stock.
• Collectively, the three trusts have shared voting and dispositive power over 3,311,499 shares, which represents approximately 5.93% of the outstanding common stock.
• The percentage ownership is calculated based on 55,875,894 shares of common stock outstanding as of September 30, 2024, as reported in Repligen's Form 10-Q filed on November 18, 2024.
• The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of Repligen Corporation.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative performance indicators or strategic announcements.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Repligen Corporation's future outlook.

Management Comments

• Nereyda Rubio and Anis Garci, as co-trustees, disclaim beneficial ownership of each reporting person's shares except to the extent of their pecuniary interest therein.
• The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing is a standard disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive dynamics within the biotechnology or life sciences sector where Repligen Corporation operates.

Management Changes

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive ownership stakes, confirming that a substantial block of shares is held by trusts associated with a deceased founder, and that these shares are not intended for control-influencing purposes.

Key Dates

Keywords

Repligen Corporation, Schedule 13G, Beneficial Ownership, Common Stock, Roy T. Eddleman Living Trust, Charitable Remainder Trust, Passive Investment, SEC Filing, Biotechnology, Life Sciences